Amgen Ventures

VC · Thousand Oaks (United States)

VC

Seed

Series A

Hardware

Healthcare

Sign up free to access full profile and submit your pitch.

About

Amgen Ventures is a venture capital arm of Amgen Inc. specializing in direct investments in early stage, seed/startup, growth capital, mid venture, later stage, and emerging companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, bone health, nephrology, metabolic disorders, neuroscience, and cardiovascular therapeutics. In oncology, it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care, including mucositis and cachexia. In nephrology, the firm focuses on renal failure and hyperparathyroidism. For inflammation, the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders, it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology, the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in Thousand Oaks, California; with additional offices in San Francisco, California; Seattle, Washington; and Cambridge, Massachusetts.

Investment Criteria